Natixis Advisors, L.P. Certara, Inc. Transaction History

Natixis Advisors, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$13.36 - $18.94 $57,314 - $81,252	-4,290 Reduced 17.06%	20,856 $289,000
Q1 2024 Apr 25, 2024	BUY	$15.65 - $19.45 $19,202 - $23,865	1,227 Added 5.13%	25,146 $450,000
Q4 2023 Feb 06, 2024	BUY	$12.12 - $18.19 $106,449 - $159,762	8,783 Added 58.03%	23,919 $420,000
Q3 2023 Nov 13, 2023	BUY	$13.9 - $19.58 $24,894 - $35,067	1,791 Added 13.42%	15,136 $220,000
Q2 2023 Aug 15, 2023	SELL	$16.89 - $24.64 $185,063 - $269,980	-10,957 Reduced 45.09%	13,345 $243,000
Q1 2023 May 11, 2023	BUY	$15.9 - $24.72 $386,401 - $600,745	24,302 New	24,302 $586,000

234

106M

26.4K

19.2K

Ticker CERT
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 159,899,008
Market Cap $1.59B
Description
Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company al...

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

Stay updated on Natixis Advisors, L.P. with notifications on news.